Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Asset Writedowns and Impairment (2023)

Historic Asset Writedowns and Impairment for Therapeutics (LENZ) over the last 1 years, with Q4 2023 value amounting to $13.3 million.

  • Therapeutics' Asset Writedowns and Impairment changed N/A to $13.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $20.6 million, marking a year-over-year change of. This contributed to the annual value of $56.6 million for FY2023, which is N/A changed from last year.
  • Per Therapeutics' latest filing, its Asset Writedowns and Impairment stood at $13.3 million for Q4 2023.
  • In the past 5 years, Therapeutics' Asset Writedowns and Impairment ranged from a high of $13.3 million in Q4 2023 and a low of $7.2 million during Q3 2023